Title here

Text here

The Leukemia & Lymphoma Society, Inc.

AKA LLS

White Plains, NY

GuideStar Quick View Everything you need to know...


Legitimacy Information

  • This organization is registered with the IRS.
  • This organization is required to file an IRS Form 990 or 990-EZ.

Institutional funders should note that an organization’s inclusion on GuideStar.org does not satisfy IRS Rev. Proc. 2011-33 for identifying supporting organizations.

Learn more about GuideStar Charity Check, the only pre-grant due diligence tool that is 100% compliant with IRS Rev. Proc 2011-33.


Forms 990 from IRS Additional Information IRS Form 990 is an annual document used by approximately one-third of all public charities to report information about their finances and operations to the federal government. GuideStar uses data from Form 990 to populate its database with financial information about nonprofit organizations. Posting Form 990 images on the GuideStar Web site is an ongoing process.

Forms 990 for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.

Annual Revenue & Expenses Additional Information Financial information on GuideStar is either digitized from Form 990 images we receive from the IRS or submitted by the nonprofits themselves through the GuideStar Exchange (990 filers cannot override Form 990 financial data). If your organization does not file a Form 990, 990-EZ, or 990-PF and you would like to have your financial data displayed in this section, join the GuideStar Exchange today!

Fiscal Year Starting: July 1, 2012
Fiscal Year Ending: June 30, 2013
Revenue
Total Revenue $290,358,467
Expenses
Total Expenses $292,394,514

Is this information up-to-date?
Claim your report and update your GuideStar Exchange profile today!

Financial data from Forms 990 for Year 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.



GuideStar Exchange Member

This organization is a Silver-level GuideStar Exchange participant, demonstrating its commitment to transparency.

Is this your organization's report?
Update your organization's information today!


Basic Organization Information

The Leukemia & Lymphoma Society, Inc.

Also Known As:
LLS
Physical Address:
White Plains, NY 10605 
EIN:
13-5644916
Web URL:
www.lls.org 
Blog URL:
community.lls.org/bl... 
NTEE Category:
G Disease, Disorders, Medical Disciplines 
G30 Cancer 
H Medical Research 
H30 Cancer Research 
Ruling Year:
2001 

Sign in or create an account to see this organization's full address, contact information, and more!


Mission Statement

The Leukemia & Lymphoma Society: We have one goal: A world without blood cancers The Leukemia & Lymphoma Society (LLS) exists to find cures and ensure access to treatments for blood cancer patients. Today, LLS is the world’s largest voluntary health agency dedicated to finding cures for leukemia, lymphoma, myeloma and other blood cancers. LLS impacts patients and their families through their 61 chapters across the United States and Canada.

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.

Financial Data

Sign in or create an account to view Revenue and Expense data for the most recent fiscal year.


Revenue and Expenses

Sign in or create an account to view this information for the most recent fiscal year.

Revenue and Expense data from Forms 990 for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart


Balance Sheet

Balance Sheet data from Forms 990 for Year 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.


Forms 990 Provided by the Nonprofit

Sign in or create an account to view Form(s) 990 for 2012, 2007, 2006.


Financial Statements

Financial Statements for 2013 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart


Annual Reports

Sign in or create an account to view this information.



Leadership (GuideStar ExchangeThe GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more. April, 2014)

Mr. Louis J. DeGennaro, Ph.D.

Profile:

Louis J. DeGennaro, Ph.D., was named interim president and CEO of The Leukemia & Lymphoma Society (LLS) in February 2014. DeGennaro has been a critical member of the LLS executive leadership team since he joined LLS in 2005. As a member of the leadership team, DeGennaro helped steward LLS operations. He was named LLS chief mission officer in 2009, with responsibility for leadership of LLS's mission functions of research, patient access, education, public policy and advocacy. He continues to serve as chief mission officer with his role as interim president and CEO. DeGennaro is recognized as a key architect of LLS's cures and access agenda to help save lives of blood cancer patients and the LLS Therapy Acceleration Program® - a venture philanthropy endeavor that demonstrates the role of nonprofit organizations in supporting drug discovery and development with the biotechnology industry. DeGennaro received his Ph.D. in biochemistry from the University of California at San Francisco and did his postdoctoral research at Yale University School of Medicine. His previous academic appointments include research group leader at Max Planck Institute in Munich, Germany, and associate professor of neurology and cell biology at the University of Massachusetts Medical School. DeGennaro has more than 25 years of research and executive management experience. His private-sector positions include senior director of molecular genetics at Wyeth Pharmaceuticals, Princeton, NJ, and executive vice president for research and development, SynX Pharma, Inc., Toronto, Canada.



Officers for Fiscal Year (IRS Form 990)

Report Added To Cart Officers for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now


Highest Paid Employees & Their Compensation (IRS Form 990)

Highest Paid Employee Data for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart


Program: Patient Services and Blood Cancer Research/Advocacy

Budget:
$196,257,539
Category:
Diseases, Disorders & Medical Disciplines
Population Served:
General Public/Unspecified

Program Description:

Joining hands to help patients cope: improving the quality of life of patients and their families. The Leukemia & Lymphoma Society offers the most comprehensive array of services to patients and families touched by blood cancers. A diagnosis of leukemia, lymphoma or myeloma brings many daily challenges. The Society is committed to providing support and guidance to patients and the health professionals who care for them. Call Center(http://www.leukemia-lymphoma.org/all_page?item_id=4261) - The Information Resource Center (IRC) provides the public, families, health professionals and people living with blood-related cancer accurate, up-to-date, disease-related information and referral services Investing in blood cancer research: LLS has invested more than $680 million in research, approximately $69 million in fiscal year 2009 alone. Programs like the Specialized Center of Research (SCOR), which brings together teams of scientists from different disciplines and our Translational Research Program, which funds research with a high probability of producing innovative patient treatments in an accelerated time frame, have directly contributed to many breakthrough cancer treatments.  Research funded by LLS has led or contributed to advances such as chemotherapy, bone marrow and stem cell transplantation and new, targeted oral therapies such as Gleevec®. Providing critical information and support for patients and their families:  We made 4.9 million contacts with patients, caregivers and healthcare professionals in fiscal year 2009, through our Information Resource Center (IRC), our award winning Web site and community-based patient service programs. We put people together with experts through Web-casts and teleconferences, and provided professional education through seminars, to extend the latest findings to a broader professional audience. Advocating for issues impacting blood cancer patients: With more than 20,000 advocacy volunteers throughout the country, our voice is being heard by those responsible for legislation to fund blood cancer research and educational programs.

Program Long-Term Success:

Program Short-Term Success:

Program Success Monitored by:

Program Success Examples:



Contractor data is available for this organization!

Independent Contractor information for 2012, 2011, 2010, 2009, 2008 is available for this organization with a subscription to GuideStar Premium Pro.

GuideStar Premium Pro also includes:

  • Comprehensive financial data, including functional expense detail, for every digitized fiscal year in GuideStar's database
  • Ability to download up to 55 fields of data for up to 1,000 organizations at a time and up to five years’ worth of Income Statement and Balance Sheet data for individual organizations
  • Comprehensive advanced search capabilities, including criteria for functional expenses, investible assets, investment income and audit & 990T filing requirements
  • Ability to save organizations and searches for quick reference
  • People search with salary range data
  • Access to all available Forms 990

More information

Upgrade Now!

Impact Summary from the Nonprofit

As of 2014, LLS has invested nearly $1 billion in research to advance therapies and save lives. From 2000 through 2013, almost 40 percent (31 of 81) of new anti-cancer drugs were FDA-approved for blood cancer patients, more first-ever approvals than for any other group of cancers, and many of these were advanced with funding from LLS. Many of these therapies are also helping patients with other cancers and other serious diseases. LLS is the leading source of free blood cancer information, education and support for patients, survivors, families and healthcare professionals. In North America, LLS’s co-pay assistance program has raised more than $200 million to date to help eligible blood cancer patients afford health-insurance premiums and prescription drug co-pays, assisting more than 36,000 patients since its inception in 2007. LLS also advocates for policies at the federal and state levels to accelerate the approval of new treatments and ensure access to quality, affordable and coordinated care. For more in-depth information about this organization's impact, view their latest annual report http://www.lls.org/aboutlls/financialinformation/annualreports/

Expert Assessment

The Leukemia & Lymphoma Society has improved the state of various blood cancers by increasing funds to conduct research and by providing education and financial services to patients. Read More »

Expert Reviews and Comments

2011 Philanthropedia Top Nonprofit

This organization is a 2011 Philanthropedia top nonprofit, recommended by experts as having high impact.

These expert reviews were generated through Philanthropedia's research methodology to identify high-impact nonprofits. Learn more


Evidence of Impact

The Leukemia & Lymphoma Society has improved the state of various blood cancers by increasing funds to conduct research and by providing education and financial services to patients.

Number of Affiliate Sites
The number of affiliate sites they have across the country, their outreach initiatives with oncology professional organizations as well as outreach initiatives to medically underserved populations underway at a number of their affiliate sites. Researcher and Faculty
Focus on Young Scientists
LLS focuses on young scientists. Researcher and Faculty
Raising Awareness
It is vital to note the importance of researching treatments for Leukemia due to its effect on children. The Leukemia and Lymphoma Society is not only the most well known organization, but it raises the most awareness which is important in finding a way to treat children with this disease. Foundation Professional
Great Resource to Other Organizations
LLS has been consistently well organized and well respected in the different states I work with. They also provide free nursing and social work CEU's for all meetings we coordinate that have at least one speaker on blood cancers or bone marrow transplant. I have been both a volunteer for LLS as well as collaborated with them on state cancer comprehensive cancer control plans/networks, as well as participated with them in coalitions, as well as had their staff as volunteers for me when putting on multi-day, multi-track meetings for regions of the country. Other
LLS has consistently been a collaborator with my organizations across many states. I have been on their advisory board in OK and also use them for CEU credits for nurses and social workers at no cost to us in many states. There has been a great deal in turnover in the OKC office over the past year or so but I think it is for the better. I don't know the details but do know some of the personalities who have been moved along. Other
Funding Research
LLS has broadened its mandate in recent years to include all blood cancers and has communicated and implemented this extension of mission effectively. It has real impact through its research funding process. Nonprofit Senior Staff
They have increased the quantity of clinical trials for pediatric cancers. Other
I know the LLS was the fusion of separate leukemia and lymphoma societies, and they make important funding contributions to research for these diseases. I think of them as similar to the ACS but only focused on "liquid" cancers. Overall good reputation, but my work is more on solid tumors, so I do not know much about operations. Researcher and Faculty
Good Patient Services
They help all blood cancer patients with financial assistance and education. Other
This organization is the result of the successful merger of two organizations a few years ago, a process that was accomplished remarkably well. They now are one of the primary sources of information and assistance for individuals with leukemia or lymphoma and a significant factor in influencing the “research agenda” for blood cancers. Other

Organizational Strengths

This organization's leadership team, its way of dealing with and recruiting volunteers, and its effective marketing strategies are reasons why the group has been so effective, according to experts.

Great Leadership
LLS has a strong leadership that engages in active partnerships with a number of other cancer organizations. Researcher and Faculty
Their leadership is outstanding, and the review process is a model for how to do this sort of thing. Researcher and Faculty
This organization is very strong from both at finances and leadership perspective. Other
Effective Marketing
This organization has very strong marketing skills and successfully helps to raise awareness about Leukemia as well as Lymphoma. The also have a very strong leadership force that helps to keep the organization at the forefront of Leukemia oriented foundations. Foundation Professional
They have strong marketing. Other
Good System of Volunteers
The staff has been excellent at collaboration as well as recruiting and keeping volunteers. The volunteers are appreciated and know that. Other
LLS has great strength in its volunteer scientists and community leaders. It also runs many participatory programs that engage volunteers. Nonprofit Senior Staff
Low Administrative Costs
It gets a maximum amount of money into patients and researchers hands. They have low administrative costs. Other

Areas for Improvement

Experts have noted that the Leukemia & Lymphoma Society could improve by engaging in more collaborations, expanding more into the realm of policy, and hiring more staff.

Stronger Focus on Children
This non-profit could improve by doing some more hands on activities with children who suffer from Leukemia in addition to the national initiatives that exist. Foundation Professional
More Collaborative Efforts
More collaboration with other blood cancer groups at the program level would be beneficial to patients with blood cancers. Nonprofit Senior Staff
Collaborate with ACS. Other
More Staff
They should spend a bit more to help local coordinators. They need more staff help as well. Other
Greater Policy Role
With their depth and strength, this organization should get more actively involved in policy issues that affect blood cancer patients and affect the pace of new drug development and approval. They are not known for being willing to take a position on controversial issues, but they have the credibility to do so. Other

Organization Data Available

Adobe PDF Format A GuideStar Premium Report in PDF format is available for this organization

Price for this Report: $125.00

This Premium Report includes:

  • Financial Data for
  • Financial Charts for
  • Forms 990 for
  • Forms 990T for
  • Audited Financial Statement for
  • Annual Reports for
  • Letter of Determination
  • Form 1023 / 1024
  • Board Members
  • Officer, Director and/or Highest Paid Employee data for


Learn more about GuideStar Premium